Corcept Therapeutics Inc.

CORT·NASDAQ·$43.96Share Price as of 11/2·$5BMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2607/29/26 10-QQ1 ended 03/31/2604/30/26 10-KFY 202502/24/26 10-QQ3 ended 09/30/2511/04/25 10-QQ2 ended 06/30/2507/31/25

Disclosures

8-KCurrent report09/23/26 8-KCurrent report07/29/26 8-KCurrent report06/17/26 8-KCurrent report06/03/26 8-KCurrent report05/28/26

Prospectuses and Registrations

S-8Registration of securities for employees05/29/26 S-8Registration of securities for employees05/31/24 S-8 POSPost-effective amendment (S-8)05/31/24 S-8 POSPost-effective amendment (S-8)05/31/24 S-8 POSPost-effective amendment (S-8)05/31/24

Proxies

DEF 14ADefinitive proxy04/17/26 DEF 14ADefinitive proxy04/25/25 DEFA14AAdditional proxy materials04/18/24 DEF 14ADefinitive proxy04/10/24 DEFA14AAdditional proxy materials05/08/23

Ownership

Form 4Insider transaction10/16/26 Form 3Initial insider ownership10/05/26 Form 4Insider transaction10/05/26 Form 4Insider transaction10/05/26 Form 4Insider transaction10/05/26

Other

UPLOADLetter from the SEC12/11/25 CORRESPCorrespondence with the SEC10/01/25 UPLOADLetter from the SEC09/18/25 ARSAnnual report to shareholders04/17/24 UPLOADLetter from the SEC08/24/23